Concepedia

Nicholas Kitchin

NK

34

Publications

22.3K

Citations

22

H-Index

2001

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

BioNTech (Germany)

SUNY Upstate Medical University

The University of Texas Medical Branch at Galveston

Nicholas Kitchin is an author at Pfizer (United States) specializing in vaccination, medicine, and vaccine safety.

ORCID

Top concepts

Publications per year

2001–2024

34

Publications

34

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents

Robert W. Frenck, Nicola P. Klein, Nicholas Kitchin et al. · New England Journal of Medicine · 2021 · 913 citations · Full text

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

Emmanuel B. Walter, Kawsar R. Talaat, Charu Sabharwal et al. · New England Journal of Medicine · 2021 · 611 citations · Full text

Rows per page

1–5 of 34